This inventor holds 1 USPTO granted patent. Top assignee: Women's and Children's Hospital. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Inventor Spotlight: Xiao-Nui Guo
Introduction
Xiao-Nui Guo is a prominent inventor based in Findon, Australia. He has made significant contributions in the field of genetics, particularly concerning the enzyme sulphamidase. His innovative work aims to improve the understanding and treatment of sulphamidase deficiency in mammals.
Latest Patents
Guo holds a noteworthy patent titled "Synthetic mammalian sulphamidase and genetic sequences encoding same." This patent focuses on the development of synthetic mammalian sulphamidase and encompasses genetic sequences that encode this enzyme. The implications of this invention are profound, as it provides tools for the investigation, diagnosis, and treatment of individuals suspected of or suffering from sulphamidase deficiency.
Career Highlights
Xiao-Nui Guo is affiliated with the Women's and Children's Hospital, where he contributes his expertise to ongoing research and development efforts. His work at the hospital emphasizes the importance of genetic research in the medical field, enhancing the lives of patients affected by genetic disorders.
Collaborations
Throughout his career, Guo has worked alongside esteemed colleagues such as John Joseph Hopwood and Hamish Steele Scott. These collaborations highlight the team-oriented nature of scientific research and the shared goal of advancing medical knowledge and treatments.
Conclusion
Xiao-Nui Guo's contributions to the field of genetics exemplify the impact of innovative research on healthcare. His patent and collaborative efforts underscore the importance of interdisciplinary cooperation in addressing complex medical challenges. As advancements in genetic research continue, Guo's work will likely play a pivotal role in improving diagnostic and therapeutic options for those with sulphamidase deficiency.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile